QL
CBAY

Quarry LP’s Cymabay Therapeutics CBAY Stock Holding History

Quarry LP’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,000
Closed -$94.5K – 1993
2023
Q4 		$94.5K Sell
4,000
-5,000
-56% -$89K 0.01% 198
2023
Q3 		$134K Buy
+9,000
New +$119K 0.03% 172

Other funds holding CBAY

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Quarry LP's CBAY Position: Q1 2024 in Review

Quarry LP sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 4,000 shares — an estimated $94.5K sold.

Quarry LP first reported a position in CBAY in Q3 2023 and held it in 2 quarters. The position peaked at $134K in Q3 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

  • Quarry LP reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Quarry LP sold 4,000 Cymabay Therapeutics shares in Q1 2024, an estimated $94.5K.
  • Quarry LP first reported a position in Cymabay Therapeutics in Q3 2023 and held it in 2 quarters.
  • Quarry LP's Cymabay Therapeutics position peaked at $134K in Q3 2023.
  • 1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Quarry LP's 13F filing for Q1 2024, filed 15 May 2024.